Literature DB >> 7214307

Malignant lymphoma of the central nervous system: a case of primary spinal intramedullary involvement.

H Mitsumoto, A C Breuer, R J Lederman.   

Abstract

Primary involvement of the spinal cord in malignant lymphoma is rare. Clinical and pathologic features of a case of malignant lymphoma initially involving the spinal cord and subsequently one cerebral hemisphere are reported and the medical literature reviewed. If malignant lymphoma of the central nervous system is diagnosed by means of brain biopsy examination, radiotherapy of any coexisting intramedullary spinal cord lesion of undetermined cause should be considered.

Entities:  

Mesh:

Year:  1980        PMID: 7214307     DOI: 10.1002/1097-0142(19800901)46:5<1258::aid-cncr2820460529>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Primary intramedullary spinal cord lymphoma: a population-based study.

Authors:  Wuyang Yang; Tomas Garzon-Muvdi; Maria Braileanu; Jose L Porras; Justin M Caplan; Xiaoming Rong; Judy Huang; George I Jallo
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

Review 2.  Hemangioblastomas and other uncommon intramedullary tumors.

Authors:  D J Miller; I E McCutcheon
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Intramedullary non-Hodgkin's lymphoma of the spinal cord: a case report and literature review.

Authors:  A C McDonald; J A Nicoll; R Rampling
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  Syringomyelia affecting the entire spinal cord secondary to primary spinal intramedullary central nervous system lymphoma.

Authors:  I Landan; J Gilroy; D E Wolfe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

5.  Nomograms Predict Survival Outcome of Primary Intramedullary Spinal Cord Lymphoma Patients.

Authors:  Qiong Wu; Zuyi Yang; Yuan Xu
Journal:  Med Sci Monit       Date:  2019-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.